Drug Type CAR-T |
Synonyms |
Target |
Mechanism CLDN18.2 modulators(Claudin 18.2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Preclinical | CN | - | |
Pancreatic Cancer | Preclinical | CN | - | |
Stomach Cancer | Preclinical | CN | - |